Key result
This document is a journal masthead and does not contain any clinical study findings.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
No clinical findings reported; leaves open platelet modulation in inflammation without new evidence.
There is growing recognition of the critical role of platelets in inflammation and immune responses. Recent studies have indicated that antiplatelet medications may reduce mortality from infections and sepsis, which suggests possible clinical relevance of modifying platelet responses to inflammation. Platelets release numerous inflammatory mediators that have no known role in haemostasis. Many of these mediators modify leukocyte and endothelial responses to a range of different inflammatory stimuli. Additionally, platelets form aggregates with leukocytes and form bridges between leukocytes and endothelium, largely mediated by platelet P-selectin. Through their interactions with monocytes, neutrophils, lymphocytes and the endothelium, platelets are therefore important coordinators of inflammation and both innate and adaptive immune responses.
No takes yet. Share an insight, caveat, or question.
A 2015 study studied this question. This document is a journal masthead and does not contain any clinical study findings.
Synapse has enriched 10 related papers. Consider them for comparative context: